NOVEMBER 1: The Jays have officially announced that they’ve extended a qualifying offer to Cabrera.
SEPTEMBER 16: The Blue Jays are pleased with Melky Cabrera both on and off the field and will make him a qualifying offer following the season with the hope of retaining the switch-hitter on a multi-year deal, reports Jon Heyman of CBS Sports. A qualifying offer, expected to fall in the $15MM range this winter, will be worth nearly as much as the two-year, $16MM pact Cabrera inked with the Blue Jays prior to the 2013 season.
As ESPN.com’s Buster Olney recently said (Insider link), issuing Cabrera a QO appears to be a “slam dunk” for Toronto. Though his season ended a bit prematurely due to a fractured pinkie finger suffered this month, Cabrera certainly put up some impressive numbers in his walk season. The 30-year-old hit .301/.351/.458 with 16 homers with slightly below-average glovework in left field. In total, Fangraphs pegs him at 2.7 wins above replacement, while Baseball-Reference valued him at 3.1.
Cabrera, of course, brings with him to free agency the baggage of having served a 50-game suspension after testing positive for synthetic testosterone back in 2012. While many were quick to point to his disappointing 2013 season — he hit just .279/.322/.360 — as evidence that he’d benefited substantially from PEDs, doctors eventually found a benign tumor on Cabrera’s spine that had to significantly impact his ability to produce.
The question, of course, will be what type of deal Cabrera can command this winter — a topic which MLBTR’s Charlie Wilmoth examined in depth in a recent Free Agent Stock Watch post. Cabrera recently told reporters that he hopes to remain in Toronto, stating that he loves the city of Toronto and suggesting that he feels indebted to a team that gave him a chance when his value was at its lowest point. I’d think a four-year deal is attainable for Cabrera on the open market, particularly after Jhonny Peralta managed to secure such a contract on the heels of a much more recent PED suspension last winter.